Report cover image

Hematology Analyzers and Reagents Market Report and Forecast 2025-2034

Publisher Expert Market Research
Published Jul 28, 2025
Length 350 Pages
SKU # EMAR20319865

Description

The global hematology analyzers and reagents market size was valued at USD 7.31 Billion in 2024, driven by the rising number of blood disorders across the globe. The market size is anticipated to grow at a CAGR of 6.00% during the forecast period of 2025-2034 to achieve a value of USD 13.09 Billion by 2034.

Hematology Analyzers and Reagents: Introduction

Hematology analyzers are used to perform a test, called complete blood count, with accuracy. This test is the first basic test that a physician asks someone to know about their health history.

Global Hematology Analyzers and Reagents Market Analysis

The rising prevalence of anemia is primarily driving the growth of the market. According to WHO, anaemia affects 571 million women and 269 million young children worldwide. The increasing initiatives by organization such as WHO to improve the accessibility status of healthcare related to anemia is driving the hematology analyzers and reagents and market growth. For instance, WHO has launched a comprehensive framework on reducing anemia. WHO has asked countries to speed up the process to reduce anaemia prevalence in women by 2025.

The increasing technological advancements in the hematology analyzers is leading to increase in demand as it can easily increase the capabilities of the laboratory.  The integration of advanced technologies, such as artificial intelligence in hematology analyzers, is aiding the global hematology analyzers and reagents and market growth as it reduces the chances of information overload and confusion. The increasing focus of key players on developing new and improved technologically advanced hematology analyzers is also driving the market growth.

Moreover, the rising number of clinical trials and research studies to improve the efficacy of hematology analyzers and reagents is directly contributing to the growth of the market. With increasing focus of key players on development of new technologies, the launch of new products in the market is aiding the growth of the market.

Global Hematology Analyzers and Reagents Market Segmentations

Hematology Analyzers and Reagents Market Report and Forecast 2025-2034 offers a detailed analysis of the market based on the following segments:

Market Breakup by Product and Services
  • Products 
  
  • Hematology Analyzers

    •   
  • 5-Part and 6-Part Hematology Analyzers

    •   
  • Point of Care Testing Hematology Analyzers

    •   
  • Semi-Automated Hematology Analyzers

    •   
  • Automated Cell Counters

    •   
  • Flow Cytometers

    •   
  • Others
    • Reagents and Consumables 
      
  • Hematology Reagents

    •   
  • Consumables

    •   
  • Controls and Calibrators

    •   
  • Slide Stainer’s

    •   
  • Others

    • Market Breakup by Technology
    • Automated Hematology Analyzers
    • Flow Cytometry
    • Specialized Hematology Analyzers
    Market Breakup by Applications
    • Anemia
    • Blood Cancer
    • Hemorrhagic Conditions
    • Infection-Related Conditions
    • Immune System Related Conditions
    • Others
    Market Breakup by End User
    • Hospital Laboratories
    • Blood Banks
    • Commercial Service Providers
    • Government Reference Laboratories
    • Research and Academic Institute
    • Others
    Market Breakup by Region
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East and Africa
    Global Hematology Analyzers and Reagents Market Overview

    The increasing prevalence of blood related disorders, like anemia and leukemia, is primarily driving the market growth. According to leukemia and lymphoma society, nearly 59,610 people are predicted to be diagnosed with leukemia by the end of 2024. The rising incidence of blood disorders such as haemophilia and blood clots across the globe are also driving the market growth as the increase in these disorders is adding further value to the overall global hematology analyzers and reagents market share. The rise in hemorrhagic conditions causing excessive bleeding internally in body organs is also anticipated to aid the demand for hematology analyzers and reagents.

    Other than the rising prevalence of these disorders, the rapid technological advancements are also likely to propel the growth of the market in the coming years. Governments and key players across the globe are investing funds and efforts to develop more advanced products, which would significantly contribute to the overall development of the market during the forecast period.

    Hematology Analyzers and Reagents Market: Competitor Landscape

    The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
    • Abbott Laboratories
    • Sysmex Corporation
    • Siemens Healthineers
    • Beckman Coulter
    • Roche Diagnostics
    • HORIBA Medical
    • Nihon Kohden Corporation
    • Boule Diagnostics
    • Mindray Medical International Limited
    • Bio-Rad Laboratories
    • Ortho Clinical Diagnostics
    • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
    • Diatron
    • EKF Diagnostics
    • Drew Scientific Inc.
    *Please Note:* The report will take 5 business days to complete, after order confirmation.

    Table of Contents

    350 Pages
    1 Preface
    1.1 Objectives of the Study
    1.2 Key Assumptions
    1.3 Report Coverage – Key Segmentation and Scope
    1.4 Research Methodology
    2 Executive Summary
    3 Global Hematology Analyzers and Reagents Market Overview
    3.1 Global Hematology Analyzers and Reagents Market Historical Value (2018-2024)
    3.2 Global Hematology Analyzers and Reagents Market Forecast Value (2025-2034)
    4 Global Hematology Analyzers and Reagents Market Landscape
    4.1 Global Hematology Analyzers and Reagents Developers Landscape
    4.1.1 Analysis by Year of Establishment
    4.1.2 Analysis by Company Size
    4.1.3 Analysis by Region
    4.2 Global Hematology Analyzers and Reagents Product Landscape
    4.2.1 Analysis by Product Type
    4.2.2 Analysis by Technology
    4.2.3 Analysis by Applications
    5 Global Hematology Analyzers and Reagents Market Dynamics
    5.1 Market Drivers and Constraints
    5.2 SWOT Analysis
    5.3 Porter’s Five Forces Model
    5.4 Key Demand Indicators
    5.5 Key Price Indicators
    5.6 Industry Events, Initiatives, and Trends
    5.7 Value Chain Analysis
    6 Global Hematology Analyzers and Reagents Market Segmentation
    6.1 Global Hematology Analyzers and Reagents Market by Product and Services
    6.1.1 Market Overview
    6.1.2 Products
    6.1.2.1 Hematology Analyzers
    6.1.2.1.1 5-Part and 6-Part Hematology Analyzers
    6.1.2.1.2 Point of Care Testing Hematology Analyzers
    6.1.2.1.3 Semi-Automated Hematology Analyzers
    6.1.2.2 Automated Cell Counters
    6.1.2.3 Flow Cytometers
    6.1.2.4 Others
    6.1.3 Reagents and Consumables
    6.1.3.1 Hematology Reagents
    6.1.3.2 Consumables
    6.1.3.3 Controls & Calibrators
    6.1.3.4 Slide Stainer’s
    6.1.3.5 Others
    6.2 Global Hematology Analyzers and Reagents Market by Technology
    6.2.1 Market Overview
    6.2.2 Automated Hematology Analyzers
    6.2.3 Flow Cytometry
    6.2.4 Specialized Hematology Analyzers
    6.3 Global Hematology Analyzers and Reagents Market by Applications
    6.3.1 Market Overview
    6.3.2 Anemia
    6.3.3 Blood Cancer
    6.3.4 Hemorrhagic Conditions
    6.3.5 Infection-Related Conditions
    6.3.6 Immune System Related Conditions
    6.3.7 Others
    6.4 Global Hematology Analyzers and Reagents Market by End User
    6.4.1 Market Overview
    6.4.2 Hospital Laboratories
    6.4.3 Blood Banks
    6.4.4 Commercial Service Providers
    6.4.5 Government Reference Laboratories
    6.4.6 Research and Academic Institute
    6.4.7 Others
    6.5 Global Hematology Analyzers and Reagents Market by Region
    6.5.1 Market Overview
    6.5.2 North America
    6.5.3 Europe
    6.5.4 Asia Pacific
    6.5.5 Latin America
    6.5.6 Middle East and Africa
    7 North America Hematology Analyzers and Reagents Market
    7.1 Market Share by Country
    7.2 United States of America
    7.3 Canada
    8 Europe Hematology Analyzers and Reagents Market
    8.1 Market Share by Country
    8.2 United Kingdom
    8.3 Germany
    8.4 France
    8.5 Italy
    8.6 Others
    9 Asia Pacific Hematology Analyzers and Reagents Market
    9.1 Market Share by Country
    9.2 China
    9.3 Japan
    9.4 India
    9.5 ASEAN
    9.6 Australia
    9.7 Others
    10 Latin America Hematology Analyzers and Reagents Market
    10.1 Market Share by Country
    10.2 Brazil
    10.3 Argentina
    10.4 Mexico
    10.5 Others
    11 Middle East and Africa Hematology Analyzers and Reagents Market
    11.1 Market Share by Country
    11.2 Saudi Arabia
    11.3 United Arab Emirates
    11.4 Nigeria
    11.5 South Africa
    11.6 Others
    12 Patent Analysis
    12.1 Analysis by Type of Patent
    12.2 Analysis by Publication year
    12.3 Analysis by Issuing Authority
    12.4 Analysis by Patent Age
    12.5 Analysis by CPC Analysis
    12.6 Analysis by Patent Valuation
    12.7 Analysis by Key Players
    13 Grants Analysis
    13.1 Analysis by year
    13.2 Analysis by Amount Awarded
    13.3 Analysis by Issuing Authority
    13.4 Analysis by Grant Application
    13.5 Analysis by Funding Institute
    13.6 Analysis by NIH Departments
    13.7 Analysis by Recipient Organization
    14 Funding Analysis
    14.1 Analysis by Funding Instances
    14.2 Analysis by Type of Funding
    14.3 Analysis by Funding Amount
    14.4 Analysis by Leading Players
    14.5 Analysis by Leading Investors
    14.6 Analysis by Geography
    15 Partnership and Collaborations Analysis
    15.1 Analysis by Partnership Instances
    15.2 Analysis by Type of Partnership
    15.3 Analysis by Leading Players
    15.4 Analysis by Geography
    16 Regulatory Framework
    16.1 Regulatory Overview
    16.1.1 US FDA
    16.1.2 EU EMA
    16.1.3 INDIA CDSCO
    16.1.4 JAPAN PMDA
    16.1.5 Others
    17 Supplier Landscape
    17.1 Abbott Laboratories
    17.1.1 Financial Analysis
    17.1.2 Product Portfolio
    17.1.3 Demographic Reach and Achievements
    17.1.4 Mergers and Acquisition
    17.1.5 Certifications
    17.2 Sysmex Corporation
    17.2.1 Financial Analysis
    17.2.2 Product Portfolio
    17.2.3 Demographic Reach and Achievements
    17.2.4 Mergers and Acquisition
    17.2.5 Certifications
    17.3 Siemens Healthineers
    17.3.1 Financial Analysis
    17.3.2 Product Portfolio
    17.3.3 Demographic Reach and Achievements
    17.3.4 Mergers and Acquisition
    17.3.5 Certifications
    17.4 Beckman Coulter
    17.4.1 Financial Analysis
    17.4.2 Product Portfolio
    17.4.3 Demographic Reach and Achievements
    17.4.4 Mergers and Acquisition
    17.4.5 Certifications
    17.5 Roche Diagnostics
    17.5.1 Financial Analysis
    17.5.2 Product Portfolio
    17.5.3 Demographic Reach and Achievements
    17.5.4 Mergers and Acquisition
    17.5.5 Certifications
    17.6 HORIBA Medical
    17.6.1 Financial Analysis
    17.6.2 Product Portfolio
    17.6.3 Demographic Reach and Achievements
    17.6.4 Mergers and Acquisition
    17.6.5 Certifications
    17.7 Nihon Kohden Corporation
    17.7.1 Financial Analysis
    17.7.2 Product Portfolio
    17.7.3 Demographic Reach and Achievements
    17.7.4 Mergers and Acquisition
    17.7.5 Certifications
    17.8 Boule Diagnostics
    17.8.1 Financial Analysis
    17.8.2 Product Portfolio
    17.8.3 Demographic Reach and Achievements
    17.8.4 Mergers and Acquisition
    17.8.5 Certifications
    17.9 Mindray Medical International Limited
    17.9.1 Financial Analysis
    17.9.2 Product Portfolio
    17.9.3 Demographic Reach and Achievements
    17.9.4 Mergers and Acquisition
    17.9.5 Certifications
    17.10 Bio-Rad Laboratories
    17.10.1 Financial Analysis
    17.10.2 Product Portfolio
    17.10.3 Demographic Reach and Achievements
    17.10.4 Mergers and Acquisition
    17.10.5 Certifications
    17.11 Ortho Clinical Diagnostics
    17.11.1 Financial Analysis
    17.11.2 Product Portfolio
    17.11.3 Demographic Reach and Achievements
    17.11.4 Mergers and Acquisition
    17.11.5 Certifications
    17.12 Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
    17.12.1 Financial Analysis
    17.12.2 Product Portfolio
    17.12.3 Demographic Reach and Achievements
    17.12.4 Mergers and Acquisition
    17.12.5 Certifications
    17.13 Diatron
    17.13.1 Financial Analysis
    17.13.2 Product Portfolio
    17.13.3 Demographic Reach and Achievements
    17.13.4 Mergers and Acquisition
    17.13.5 Certifications
    17.14 EKF Diagnostics
    17.14.1 Financial Analysis
    17.14.2 Product Portfolio
    17.14.3 Demographic Reach and Achievements
    17.14.4 Mergers and Acquisition
    17.14.5 Certifications
    17.15 Drew Scientific Inc.
    17.15.1 Financial Analysis
    17.15.2 Product Portfolio
    17.15.3 Demographic Reach and Achievements
    17.15.4 Mergers and Acquisition
    17.15.5 Certifications
    18 Global Hematology Analyzers and Reagents Market - Distribution Model (Additional Insight)
    18.1 Overview
    18.2 Potential Distributors
    18.3 Key Parameters for Distribution Partner Assessment
    19 Key Opinion Leaders (KOL) Insights (Additional Insight)
    20 Company Competitiveness Analysis (Additional Insight)
    20.1 Very Small Companies
    20.2 Small Companies
    20.3 Mid-Sized Companies
    20.4 Large Companies
    20.5 Very Large Companies
    21 Payment Methods (Additional Insight)
    21.1 Government Funded
    21.2 Private Insurance
    21.3 Out-of-Pocket

    Pricing

    Currency Rates
    How Do Licenses Work?

    How Do Licenses Work?

    The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

    • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

    • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

    • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

    • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

    • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

    License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

    Head shot

    Questions or Comments?

    Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
    Chat Now
    Contact Us